Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market


Director's Report

You can view full text of the latest Director's Report for the company.



DIRECTORS' REPORT

Bajaj Consumer Care Ltd.

GO
Market Cap. ( ₹ in Cr. ) 5286.76 P/BV 6.40 Book Value ( ₹ ) 63.22
52 Week High/Low ( ₹ ) 692/243 FV/ML 1/1 P/E(X) 27.80
Book Closure 09/08/2024 EPS ( ₹ ) 14.56 Div Yield (%) 0.00
Year End :2026-03 

The Board of Directors is pleased to present the Twentieth Annual Report of Bajaj Consumer Care Limited (“BCCL" or “the
Company") for the financial year ended March 31, 2026.

In compliance with the applicable provisions of the Companies Act, 2013 (“the Act") and the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations"), this report covers the
financial results and other developments during the financial year from April 1, 2025 to March 31, 2026.

Financial Performance

The summarised Standalone financial results of the Company for the Financial Year ended March 31,2026 are presented below:

Particulars

Financial year ended

Financial year ended

March 31,2026

March 31,2025

Total Income

11 1,779.90

97,829.27

Profit before interest, depreciation and tax

25,103.72

16,796.91

Finance cost

159.03

53.72

Depreciation

1,464.70

974.16

Profit before tax

23,479.99

15,769.03

Provision for taxation - Income Tax

4,106.93

2,755.16

Profit after tax

19,373.06

13,013.87

Other comprehensive income

19.84

(102.64)

Total comprehensive income

19,392.90

12,911.23

Balance brought forward from previous year

70,905.79

58,622.69

Retained earnings available for appropriation

71,343.22

70,905.79

Appropriations -

- Dividend /Interim dividend

-

-

- Balance carried to balance sheet

71,343.22

70,905.79

During the period under review, the Company recorded total
revenue of INR 1 1 1,779.90 lakh as compared to 97,829.27 lakh
in the previous year. Profit before Tax was INR 23,479.99 lakh
as against INR 15,769.03 lakh in the previous year. The Profit
after Tax stood at INR 19,373.06 lakh as compared to the
Profit after Tax of INR 13,013.87 lakh in the previous year. The
operations and financial results of the Company are elaborated
in the Management Discussion and Analysis Report.

Material changes and commitments

There are no material changes & commitments which affects
the financial position of the Company between the end of
financial year 2025-26 and the date of this report. Further,
there is no change in the nature of business of the Company.

Transfer to Reserves

Your Directors do not propose to transfer any
amount to Reserves.

Dividend Distribution Policy

Your Company's dividend distribution philosophy aims to
appropriately reward shareholders through distribution of
profits while ensuring sufficient funds are retained for growth
and strategic initiatives. Pursuant to Regulation 43A of the
SEBI Listing Regulations, the Company has formulated a
Dividend Distribution Policy, which sets out the parameters
and circumstances to be considered by the Board while
declaring dividends. The said Policy is available on the
Company's website and can be accessed using the link:
https://www.baiaiconsumercare.com/policies.php

Dividend

The Board of Directors has not recommended any dividend
for the financial year under review.

Share Capital

The paid-up Equity Share Capital of the Company as on March
31, 2026 was Rs. 13,06,18,321 divided into 13,06,18,321

equity shares of Re. 1/- each as against Rs. 13,70,52,803
divided into 13,70,52,803 equity shares of Re. 1/- each as on
March 31, 2025.

During the year under review, the company has extinguished
64,34,482 equity shares pursuant to the buyback approved by
the Board of Directors at its meeting held on July 24, 2025
and the shareholders vide postal ballot, result of which was
declared on August 29, 2025.

Buyback of equity shares

The Board of Directors of the Company, at its meeting held
on July 24, 2025, approved the buyback of up to 64,34,482
(Sixty Four Lakh Thirty Four Thousand Four Hundred Eighty
Two) Equity Shares, representing 4.69% of the total number
of Equity Shares in the paid-up equity share capital of the
Company as at March 31, 2025, from the shareholders/
beneficial owners of Equity Shares as on the Record Date, i.e.,
Friday, September 5, 2025, on a proportionate basis through
the "tender offer" process, in accordance with the SEBI (Buy¬
Back of Securities) Regulations, 2018, at a price of INR 290/-
(Indian Rupees Two Hundred and Ninety only) per Equity
Share, payable in cash, for an aggregate maximum amount
of INR 18,660 Lakh (Indian Rupees Eighteen Thousand Six
Hundred and Sixty Lakh only) ("Buyback Offer Size").

The Buyback Offer Size excludes transaction costs. The
Buyback Offer Size represented 23.70% and 24.88% of
the aggregate of the Company's fully paid-up equity share
capital and free reserves as per the audited standalone and
consolidated financial statements of the Company for the
financial year ended March 31, 2025, respectively, being the
latest audited financial statements available as on the date of
the Board meeting approving the Buyback.

The Company adopted the tender offer route for the purpose
of the Buyback. The Buyback was implemented through
the "Mechanism for acquisition of shares through Stock
Exchange" in accordance with the applicable provisions of
the SEBI (Buy-Back of Securities) Regulations, 2018 and
the relevant circulars issued by the Securities and Exchange
Board of India ("SEBI"), including Circular No. CIR/CFD/
POLICYCELL/1/2015 dated April 13, 2015, Circular No. CFD/
DCR2/CIR/P/2016/131 dated December 9, 2016, and Circular
No. SEBI/HO/CFD/DCR-III/CIR/P/2021/615 dated August 13,
2021, as amended from time to time, and such other circulars
or notifications as may be applicable.

The Buyback opened on Thursday, September 1 1, 2025 and
closed on Wednesday, September 17, 2025.

Pursuant to the Buyback, 64,34,482 (Sixty-Four Lakh Thirty-
Four Thousand Four Hundred Eighty-Two) Equity Shares
were bought back at a price of INR 290/- (Indian Rupees Two
Hundred and Ninety only) per Equity Share.

The total amount utilised for the Buyback was INR 18,660
Lakh (Indian Rupees Eighteen Thousand Six Hundred and
Sixty Lakh only), excluding transaction costs.

Acquisition of Vishal Personal Care Limited

The Board of Directors of the Company, at its meeting held
on February 14, 2025, approved the execution of a Share
Purchase-cum-Shareholders' Agreement ("SPSHA") with
Peepul Capital Fund III LLC, Vishal Personal Care Private
Limited ("Target Company") and other parties, for the
acquisition of 100% of the equity share capital of the Target
Company in two tranches, comprising 49% (forty-nine
percent) in the first tranche and the remaining 51% (fifty-one
percent) in the second tranche.

The Company acquired 49% of the equity share capital in
the first tranche, pursuant to which the Target Company
became an Associate Company of the Company with effect
from March 10, 2025. During the current financial year, the
Company acquired the remaining 51% of the equity share
capital, and consequently, Vishal Personal Care Private
Limited became a wholly owned subsidiary of the Company
with effect from May 16, 2025.

Demerger

During May 2025, the Company completed the acquisition
of the remaining 51% stake in Vishal Personal Care Limited
("VPCL"), consequent to which VPCL became a wholly owned
subsidiary of the Company.

VPCL operates through two distinct segments, namely: (i)
Manufacturing and Distribution of Consumer Products,
comprising the manufacture, distribution and sale of products
across skin care, body care and hair care categories; and (ii)
Trademark Licensing and Other Business. These segments
have distinct risk-return profiles, operational dynamics and
growth drivers.

In line with the Company's strategy to enhance operational
efficiency and create long-term value, the Board of
Directors, at its meeting held on July 24, 2025, approved a
Scheme of Demerger for the transfer of the Manufacturing
and Distribution business of VPCL to Bajaj Consumer Care
Limited ("BCCL" or the "Company").

The proposed demerger is expected to, inter alia, enable
sharper business focus, drive operational synergies, improve
resource utilization and result in cost efficiencies. It is also
expected to enhance the Company's market reach, strengthen
cash flows and create greater value for stakeholders.

The Scheme of Arrangement between VPCL and BCCL, under
Sections 230 to 232 of the Companies Act, 2013, provides
for the transfer of the Manufacturing and Distribution
undertaking of VPCL to the Company on a going concern
basis, with an appointed date of March 15, 2025 (or such other
date as may be approved by the Hon'ble National Company
Law Tribunal ("NCLT").

The Scheme has received approval from the Hon'ble NCLT,
Jaipur. Upon the Scheme becoming effective, all assets,
liabilities, employees, contracts and other business elements
pertaining to the said undertaking shall stand transferred to
and vested in the Company.

The transaction will be accounted for in accordance with
applicable accounting standards using the pooling of
interest method, with assets and liabilities recorded at their
existing book values.

The residual business of VPCL, primarily relating to trademark
licensing and allied activities, will continue to remain with
VPCL. As VPCL is a wholly owned subsidiary, the Scheme
does not involve any issuance of shares or cash consideration.

Employee Restricted Stock Unit Plan 2018

The Members of the Company, at the Annual General Meeting
held on July 23, 2018, approved the Employee Restricted
Stock Unit Plan, 2018 ("RSU 2018"), authorising the grant
of not more than 7,37,500 restricted stock units to eligible
employees, in one or more tranches, with each unit conferring
a right to apply for one Equity Share of the Company, subject
to the terms and conditions of the Plan.

The disclosures as required under the SEBI (Share Based
Employee Benefits and Sweat Equity) Regulations, 2021
are annexed to this Report as
Annexure-1 and are also
available on the website of the Company at
https://www.
baiaiconsumercare.com/policies.

Particulars of Loans, Guarantees and
Investments

Details of loans, guarantees and investments covered under
the provisions of Section 186 of the Companies Act, 2013 are
provided in the Notes to the Financial Statements forming
part of this Annual Report.

Subsidiaries and Associate Companies

As on March 31,2026, the Company had the following unlisted
subsidiaries/associate namely:

• Uptown Properties and Leasing Private Limited

• Bajaj Bangladesh Limited (wholly owned subsidiary)

• Bajaj Corp International (FZE) (wholly owned subsidiary)

• Vishal Personal Care Limited (wholly owned subsidiary)

Out of the above subsidiaries, Uptown Properties and Leasing
Private Limited is a "Material Subsidiary" in terms of the
SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015. The Policy for Determining Material
Subsidiaries, as approved by the Board, is available on the
website of the Company at
https://www.bajajconsumercare.
com/policies.php.

Pursuant to the provisions of Section 129 of the Act read with
the Companies (Accounts) Rules, 2014, a separate statement
containing the salient features of the financial statements
of the Company's subsidiaries, in the prescribed Form AOC-
1, is attached to the financial statements forming part of
this Annual Report.

Subsidiaries Operations

Uptown Properties and Leasing Private Limited
(Uptown)

During the Financial Year ended March 31, 2026, the net Loss
of Uptown was INR 24.84 lakh as against net loss of INR 26.24
lakh of the previous Financial Year.

The Company is into the business of construction and leasing
of commercial space.

Bajaj Bangladesh Limited (BBL)

During the financial year ended March 31,2026, BBL achieved
total revenue of INR 1,495.56 lakh in FY 2025-26 as compared
to INR 1426.31 lakh in previous financial year. Net loss for the
current FY 2025-26 was at INR 13.52 lakh as against net loss
of INR 224.68 lakh of the previous financial year.

Bajaj Corp International (FZE)

During the financial year ended March 31, 2026, FZE achieved
total revenue of INR1,562.71 lakh as compared to INR
1,800.92 lakh of the previous financial year. Net Loss for the
current FY 2025-26 was INR 336.59 lakh as against net loss of
INR 291.36 lakh of the previous financial year.

Vishal Personal Care Limited (VPCL)

VPCL became a fully owned subsidiary of BCCL with effect
from 16 May 2025. Thereafter VPCL achieved total revenue of
INR 5,118.96 lakh. Net loss for the period was INR 38.94 lakh.
Consequently, the financial performance for FY 2025-26 is not
comparable with that of the previous financial year. The other
details have been provided in AOC-1.

Consolidated Financial Statements

The Consolidated Financial Statements of the Company
have been prepared in accordance with the applicable Indian
Accounting Standards prescribed by the Ministry of Corporate
Affairs and form part of this Annual Report.

In accordance with Section 136 of the Act, the audited
standalone and consolidated financial statements of the
Company, together with the audited financial statements of
each of its subsidiaries and all other documents required to be
attached thereto, are available on the website of the Company
at
https://www.baiaiconsumercare.com/financial-result.

These documents are also available for inspection by the
Members at the Registered Office of the Company during
business hours on all working days, except Saturdays,
Sundays and National Holidays, up to the date of the 20th
Annual General Meeting ("AGM”).

Management Discussion and Analysis Report

The Management Discussion and Analysis Report is presented
in a separate section forming part of this Annual Report.

Corporate Social Responsibility (CSR) Initiatives

In accordance with the requirements of the provisions of
Section 135 of the Act, the Company has constituted a CSR
Committee. The Company has also formulated a CSR Policy
which is available on Company's website at
https://www.
baiaiconsumercare.com/policies.php.

During the year under review, in compliance with the provisions
of Section 135 of the Act, the Companies (Corporate Social
Responsibility) Rules, 2014 and the various notifications/
circulars issued by the Ministry of

Corporate Affairs, the Company has spent Rs. 345.70 lakh on
permitted CSR activities through Kamalnayan Jamnalal Bajaj
Foundation (the implementing agency engaged in activities
specified in Schedule VII of the Act). Detailed information on
CSR policy, its salient features, CSR initiatives undertaken
during the year, details pertaining to spent amount are given
in
Annexure-2 to this Directors' Report.

Business Risk Management

The Company, like any other enterprise, is exposed to various
business risks, both internal and external in nature. One of
the key risks faced in the current business environment is the
wide and frequent fluctuation in the prices of raw materials.
Any significant increase in raw material costs may exert
pressure on the Company's operating margins.

Further, inflationary trends in the economy and adverse
macroeconomic developments may impact consumer
spending power. This could lead to down-trading from
branded to non-branded products, which may, in turn, affect
the Company's operating performance.

The Company operates in a highly competitive FMCG market,
where competitors may possess greater financial strength to
invest aggressively in advertising and marketing, as well as
greater flexibility to respond swiftly to changing economic and
business conditions. An increase in competitive intensity may
have a material adverse impact on the Company's market
share and sales performance.

Additionally, any unexpected changes in the regulatory
framework, including those relating to fiscal benefits and
other related matters, may affect the Company's operations
and profitability.

A key determinant of the Company's ability to create sustainable
value lies in its capacity and willingness to identify, assume, and
manage risks effectively and efficiently. The Company remains
fully cognizant of the aforementioned risks and, as part of its
business strategy, has established appropriate mechanisms to
mitigate them through timely and proactive action.

The Company has implemented a robust Business Risk
Management (BRM) framework designed to identify and
evaluate business risks and opportunities. The framework
aims to enhance transparency, minimise potential adverse
impacts on business obiectives, and strengthen the
Company's competitive advantage. The details of the Risk
Management Policy are available on the Company's website
at
https://www.baiaiconsumercare.com/policies.

In the opinion of the Board of Directors, none of the above-
mentioned risks threaten the existence of the Company.

Vigil Mechanism/ Whistle-Blower Policy & Code
of Conduct

The Company has adopted a Whistle-Blower Policy for
Directors, employees and business partners to report genuine
concerns, unethical behaviour, actual or suspected fraud, or
violations of the Company's Code of Conduct.

The mechanism provides for adequate safeguards against
victimisation of persons who avail of the facility and ensures
direct access to the Chairperson of the Audit Committee in
appropriate or exceptional cases. The Company affirms that
no personnel have been denied access to the Audit Committee.

The detailed framework and functioning of the Vigil
Mechanism are elaborately described in the Corporate
Governance Report forming part of this Annual Report. The
Whistle-Blower Policy is available on the Company's website
at
https://www.baiaiconsumercare.com/policies.

Further, the Company's Code of Conduct reinforces its
commitment to ethical business practices and integrity. The
Code clearly defines the standards of behaviour expected
from Directors and employees and outlines the processes for
addressing and resolving any breaches thereof.

Remuneration Policy

Pursuant to the provisions of Section 178 of the Act
and Regulation 19 of the SEBI Listing Regulations,
the Board of Directors, on the recommendation of the
Nomination, Remuneration and Corporate Governance
Committee, has formulated and adopted a Nomination and
Remuneration Policy.

The Policy lays down the criteria for appointment, re¬
appointment and removal of Directors, Key Managerial
Personnel and Senior Management personnel. It also
sets out the framework for remuneration, performance
evaluation, and succession planning. Further, the Policy
includes the criteria for determining qualifications, positive
attributes, independence of Directors and other matters as
prescribed under Section 178(3) of the Act and applicable
SEBI Listing Regulations.

The Committee is also entrusted with the responsibility of
developing and recommending to the Board a set of Corporate
Governance Guidelines to strengthen governance practices
within the Company.

The Nomination and Remuneration Policy is available on the
Company's website at at
https://www.baiaiconsumercare.
com/policies.php.

The salient features of the Nomination and Remuneration
Policy are as follows:

• To identify individuals who are qualified to become
Directors and members of Senior Management, in
accordance with the criteria approved by the Board,
and to periodically review the structure, composition,

functioning and performance of the Board, its
Committees and Senior Management, and recommend
changes, as considered necessary;

• To recommend to the Board the appointment of new
Directors in the event of resignation of existing Directors
or pursuant to a planned expansion of the Board;

• To recommend to the Board the composition of various
Committees of the Board;

• To formulate the criteria for evaluation of the Board and
Independent Directors;

• To determine the criteria for qualifications, positive
attributes and independence of Directors;

• To recommend to the Board a remuneration policy
for Directors, Key Managerial Personnel and
other employees;

• To develop and recommend to the Board a set of
Corporate Governance Guidelines;

• To oversee the performance evaluation of the Board, its
Committees and the Management;

• To review the Company's policies and processes in
key areas of Corporate Governance, other than those
specifically assigned to other Board Committees, with a
view to ensuring adherence to best governance practices;

• To examine the impact of significant regulatory and
statutory changes affecting the governance practices of
the Company and recommend appropriate measures for
implementation;

• To regularly review and strengthen the Company's
organisational health by improving the hiring, retention,
motivation, development, deployment and conduct of
management and other employees.

In this context, the Committee also reviews the framework
and processes for motivating and rewarding performance at
all levels of the organisation. It evaluates the compensation
structure and recommends to the Board all forms of
remuneration payable to Directors, Key Managerial Personnel,
Senior Management and other employees of the Company.

Board of Directors
Appointment & Cessation

Pursuant to the provisions of Section 161(1) of the Act and
the Articles of Association of the Company, the Board of
Directors, based on the recommendation of the Nomination,

Remuneration and Corporate Governance Committee, at its
meeting held on May 5, 2025, approved the re-appointment
of Mr. Sumit Malhotra (DIN: 02183825) as a Non-Executive,
Non-Independent Director of the Company for a term of five
(5) years with effect from July 1, 2025, subject to the approval
of the Members at the ensuing Annual General Meeting.

Further, the Members of the Company at the 19th Annual
General Meeting held on August 1 1, 2025, approved the re¬
appointment of Mr. Sumit Malhotra as a Non-Executive, Non¬
Independent Director of the Company for a period of five (5)
years with effect from July 1, 2025.

Retirement by Rotation

In accordance with the provisions of Section 152 and other
applicable provisions, if any, of the Act, not less than two-
thirds of the total number of Directors, excluding Independent
Directors, are liable to retire by rotation. One-third of these
Directors are required to retire at every Annual General Meeting
and, being eligible, may offer themselves for re-appointment.

At the ensuing Annual General Meeting ("AGM”), Mr.
Kushagra Bajaj (DIN: 00017575), Director of the Company,
retires by rotation and being eligible, has offered himself for
re-appointment.

A brief profile of Mr. Kushagra Bajaj along with the additional
disclosures required pursuant to Regulation 36(3) of the SEBI
Listing Regulations and the applicable Secretarial Standards
on General Meetings, is provided in the Annexure to the
Notice convening the AGM.

The Board of Directors recommends his re-appointment for
the approval of the Members at the ensuing AGM.

Number of Meetings of the Board

The Board of Directors met six (6) times during the financial year
2025-26 on May 5, 2025, June 24, 2025, July 24, 2025, August 11,
2025, November 10, 2025 and January 21, 2026. The maximum
interval between any two meetings did not exceed one hundred
and twenty (120) days, as prescribed under Regulation 17 of
the SEBI Listing Regulations, Section 173 of the Act and the
Secretarial Standard on Meetings of the Board of Directors.

Annual evaluation by the Board

Pursuant to the applicable provisions of the Act and the SEBI
Listing Regulations, the Board of Directors carried out an
annual evaluation of its own performance, the performance
of its committees and that of individual Directors, including
the Chairman of the Board.

The Nomination, Remuneration & Corporate Governance
Committee has defined the criteria for evaluation of the Board,
its Committees and Directors. The evaluation was conducted
through a structured questionnaire prepared separately for
the Board, Committees, Chairman and individual Directors,
covering various aspects of performance and effectiveness.

The Board's performance was evaluated on parameters
including, inter alia, degree of fulfilment of key responsibilities,
Board structure and composition, establishment and
effective functioning of Committees, delineation of roles and
responsibilities, effectiveness of Board processes, quality and
timeliness of information flow and overall governance oversight.

The performance of individual Directors was evaluated on
parameters such as attendance and active participation in Board
and Committee Meetings, contribution to discussions and decision¬
making, guidance and support to management, professional
qualifications, experience, knowledge and competency,
independence of judgment, integrity, adherence to the Company's
Code of Conduct and, in case of Independent Directors, compliance
with the Code for Independent Directors prescribed under the Act.

The Chairman was evaluated, inter alia, on leadership
qualities, setting the strategic agenda of the Board, promoting
open and constructive discussions, encouraging active
participation by all Directors and ensuring effective decision¬
making processes.

The Committees of the Board were assessed on the degree
of fulfilment of their key responsibilities, adequacy of
composition, effectiveness of meetings and compliance with
applicable statutory requirements.

In a separate meeting of Independent Directors, performance
of the Chairman and Non-Independent Directors was
evaluated, and the Independent Directors also reviewed the
performance of the Board as a whole. The performance
evaluation of Independent Directors was carried out by the
entire Board, excluding the Director being evaluated.

The Directors expressed satisfaction with the evaluation
process and its outcomes.

The detailed policy on evaluation of the Board's performance
is available on the Company's website at
https://www.
baiaiconsumercare.com/policies.php.

Familiarisation Programme for Independent
Directors

Pursuant to the provisions of Regulation 25 of the SEBI
Listing Regulations, the Company has formulated a

programme for familiarising the Independent Directors
with their roles, rights, and responsibilities within the
Company, as well as the nature of the industry in which the
Company operates, through various initiatives. The details
of the aforesaid programme are available on the Company's
website at
https://www.bajajconsumercare.com/investors-
familiarization-programme.

Board Committees

A. Audit Committee

The current composition of the Audit Committee
comprises the following members:

1. Mr. Jagdish Acharya [Independent Director],

Chairman of the Committee

2. Mr. Anupam Dutta, [Independent Director] Member

3. Mr. K. S. Narayanan, [Independent Director] Member

4. M s. Lilian J essi e Pau l [I ndependent

Director], Member

B. Nomination, Remuneration & Corporate

Governance Committee

The current composition of the Nomination,

Remuneration & Corporate Governance Committee
comprises the following members:

1. Mr. Jagdish Acharya [Independent Director],

Chairman of the Committee

2. Mr. Anupam Dutta [Independent Director], Member

3. Ms. Lilian Jessie Paul [Independent

Director], Member

C. Stakeholders Relationship Committee

The current composition of the Stakeholders Relationship
Committee comprises the following members:

1. Mr. K. S. Narayanan [Independent Director],
Chairman of the Committee

2. Mr. Kushagra Nayan Bajaj [Non-Executive, Non¬
Independent Director], Member

3. Mr. Naveen Pandey [Non-Independent, Executive
Director], Member

4. Mr. Sumit Malhotra [Non-Executive, Non¬
Independent Director], Member

5. Mr. Vimal Chandra Nagori [Non-Executive, Non¬
Independent Director], Member

D. Corporate Social Responsibility (CSR) Committee

The current composition of the Corporate

Social Responsibility Committee comprises the

following members:

1. Mr. Jagdish Acharya [Independent Director],

Chairman of the Committee

2. Mr. Naveen Pandey [Non-Independent, Executive
Director], Member

3. Mr. Sumit Malhotra [Non-Executive, Non¬

Independent Director], Member

4. Mr. Vimal Chandra Nagori [Non-Executive, Non¬
Independent Director], Member

E. Risk Management & ESG Committee

The current composition of the Risk Management & ESG

Committee comprises the following members:

1. Mr. Anupam Dutta [Independent Director],

Chairman of the Committee

2. Mr. Naveen Pandey [Non-Independent, Executive
Director], Member

3. Ms. Lilian Jessie Paul [Independent, Non-Executive
Director], Member

4. Mr. Rajesh Menon [Head-Supply Chain, Operations
and IT], Member

F. Buyback Committee

The current composition of the Buyback Committee

comprises the following members:

1. Mr. Kushagra Bajaj [Non-Executive, Non¬
Independent Director], Chairman

2. Mr. Naveen Pandey [Non-Independent, Executive
Director], Member

3. Mr. Vimal Chandra Nagori [Non-Executive, Non¬
Independent Director], Member

Directors and Key Managerial Personnel (KMP)

Mr. Naveen Pandey (DIN: 09584377) was appointed as Managing
Director of the Company w.e.f. July 01, 2025 for a period of five
consecutive years till June 30, 2030 pursuant to retirement of
Mr. Jaideep Nandi (DIN: 06938480) as Managing Director w.e.f.
June 30, 2025 upon completion of his term of five years. The
board comprises the following Directors as on March 31, 2026:

Mr. Kushagra Bajaj, Non-Executive Chairman

Mr. Naveen Pandey, Managing Director

Mr. Sumit Mathotra, Non-Executive, Non-Independent

Mr. Vimat Chandra Nagori, Non-Executive, Non-Independent

Mr. Jagdish Acharya, Non-Executive, Independent

Mr. Anupam Dutta, Non-Executive, Independent

Mr. K. S. Narayanan, Non-Executive, Independent

Ms. Lilian Jessie Paul, Non-Executive, Independent

In terms of the provisions of Section 203 of the Companies
Act, 2013, following are the KMPs of the Company:

Mr. Naveen Pandey, Managing Director
Mr. D. K. Maloo, Chief Financial Officer
Mr. Vivek Mishra, Head-Legal & Company Secretary

Declaration by Independent Directors

The Independent Directors of the Company have submitted
declaration of Independence confirming that they meet the
criteria of independence under Section 149(6) of the Act and
SEBI Listing Regulations.

All the Independent Directors of the Company have also
confirmed that they are not aware of any circumstance or
situation, which exist or may be reasonably anticipated, that
could impair or impact their ability to discharge their duties with
an objective independent judgement and without any external
influence and that they are independent of the management.
Further, it is also confirmed that they have complied with the
provisions regarding Independent Directors' registration with
the databank maintained by The Indian Institute of Corporate
Affairs ('IICA') and online proficiency self-assessment test
conducted by the IICA unless exempted.

The Board is of the opinion that the Independent Directors
of the Company possess requisite qualifications, experience
and expertise and they hold highest standards of integrity.

Directors’ Responsibility Statement

To the best of their knowledge and belief and according to
the information and explanations obtained by them, your
Directors make the following statements in terms of Section
134(5) of the Act:

(a) that in the preparation of the annual financial statements
for the year ended March 31, 2026, the applicable
accounting standards have been followed along with
proper explanation relating to material departures, if any;

(b) that such accounting policies as mentioned in the Notes
to the Financial Statements have been selected and
applied consistently and judgement and estimates have
been made that are reasonable and prudent so as to give
a true and fair view of the state of affairs of the Company
as at March 31, 2026 and of the profit of the Company for
the year ended on that date;

(c) that proper and sufficient care has been taken for
the maintenance of adequate accounting records in
accordance with the provisions of the Companies Act,
2013 for safeguarding the assets of the Company and for
preventing and detecting fraud and other irregularities;

(d) that the annual financial statements have been prepared
on a going concern basis;

(e) that proper internal financial controls were in place
and that the financial controls were adequate and were
operating effectively;

(f) that systems to ensure compliance with the provisions
of all applicable laws were in place and were adequate
and operating effectively.

Related Party Transactions

The Board of Directors has adopted a Policy on Related
Party Transactions. The Policy is available on the Company's
website at
https://www.baiaiconsumercare.com/policies.php.

The Policy sets out the mechanism for identification,
review, approval, disclosure and reporting of related party
transactions in compliance with applicable laws and
regulatory requirements.

During the Financial Year under review, all contracts/
arrangements/transactions entered into or modified with
related parties were in the ordinary course of business and
on an arm's length basis. All such transactions were placed
before the Audit Committee for prior approval, except those
covered under omnibus approval granted in accordance with
applicable provisions of the Act and SEBI LODR.

No material related party transactions were entered into
during the Financial Year. Further, the Company has not
entered into any transaction of a material nature with
its Promoters, subsidiaries of Promoters, Directors, Key
Managerial Personnel or their relatives that may have a
potential conflict with the interests of the Company.

Accordingly, the disclosure of related party transactions in
Form AOC-2, as required under Section 134(3)(h) of the Act

read with Rule 8(2) of the Companies (Accounts) Rules, 2014,
is not applicable for the Financial Year under review.

Details of related party transactions, as required under the
applicable accounting standards, form part of the notes to the
financial statements included in this Annual Report.

Internal Financial Controls

The Company has established an internal financial control
system commensurate with the size, scale and complexity of
its operations, and such controls are operating effectively.

The internal financial control framework has been designed
considering the nature of activities carried out at various
locations and across business operations. These controls
provide reasonable assurance with regard to the orderly and
efficient conduct of business, adherence to the Company's
policies, safeguarding of assets, prevention and detection
of frauds and errors, and the accuracy and completeness
of accounting records, including the timely preparation of
reliable financial information.

The Internal Auditor periodically evaluates the adequacy and
effectiveness of the internal control systems, accounting
procedures and policies adopted by the Company. Based on
the internal audit reports, the respective process owners
undertake necessary corrective actions to strengthen the
control environment.

Significant audit observations and the status of corrective
actions thereon are placed before the Audit Committee of the
Board for its review and oversight.

Auditors

(a) Statutory Auditors

The Members of the Company at the 16th Annual
General Meeting ("AGM") held on August 1, 2022
approved the appointment of M/s. Chopra Vimal & Co.,
Chartered Accountants (Firm Registration No. 06456C),
as the Statutory Auditors of the Company for a term of
five consecutive years, to hold office from the conclusion
of the 16th AGM until the conclusion of the 21st AGM
of the Company.

M/s. Chopra Vimal & Co. have confirmed that they are
within the limits prescribed under Section 141(3)(g) of
the Act and are not disqualified from being appointed
as Statutory Auditors in terms of Sections 139 and
141 of the Act read with the Companies (Audit and
Auditors) Rules, 2014.

As required under Regulation 33(1)(d) of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations,
2015, the Statutory Auditors have confirmed that they
hold a valid certificate issued by the Peer Review Board
of the Institute of Chartered Accountants of India ("ICAI").

The Report of the Statutory Auditors on the financial
statements for the Financial Year under review does not
contain any qualification, reservation, adverse remark
or disclaimer. The observations, if any, contained in the
Auditor's Report read together with the notes to the
financial statements are self-explanatory and therefore
do not call for any further explanation pursuant to
Section 134(3)(f) of the Act.

During the Financial Year under review, the Statutory
Auditors have not reported any instance of fraud under
Section 143(12) of the Act. Accordingly, no details
are required to be disclosed under Section 134(3)(c)
(a) of the Act.

(b) Secretarial Auditor

Pursuant to the provisions of Section 204 of the Act
read with Rule 9 of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014,
and Regulation 24A of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("SEBI
LODR"), the Members of the Company have approved the
appointment of Mr. Hitesh J. Gupta, Practicing Company
Secretary (Firm Registration No. I2013MH1 107800), as
the Secretarial Auditor of the Company for a term of five
(5) consecutive financial years commencing from April
1, 2025 up to March 31, 2030 to conduct the Secretarial
Audit of the Company.

The Secretarial Audit Report for the Financial Year
under review, issued by the Secretarial Auditor, does not
contain any qualification, reservation, adverse remark or
disclaimer and is annexed herewith as
Annexure - 3 to
this Director's Report.

Cost Audit

The Ministry of Corporate Affairs, vide its Notification dated
December 31, 2014, amended the Companies (Cost Records
and Audit) Rules, 2014 through the Companies (Cost Records
and Audit) Amendment Rules, 2014.

In terms of the said Amendment Rules and considering the
nature of the Company's business activities, the Company is
not required to maintain cost records or to have its cost records

audited for the Financial Year under review. Accordingly, the
requirement of Cost Audit is not applicable to the Company.

Reporting of Frauds

There was no instance of fraud during the year under review,
which required the Statutory Auditors to report to the Audit
Committee and/ or Board under Section 143(12) of the Act
and Rules made thereunder.

Corporate Governance Report and Certificate

In compliance with Regulation 34 read with Schedule V(C) of
SEBI Listing Regulations, a report on Corporate Governance
and the certificate as required under Schedule V(E) of SEBI
Listing Regulations received from the Statutory Auditors of
the Company, forms part of this Annual Report.

Compliance of Corporate Governance Standards
of New York Stock Exchange (NYSE)

The Company, to achieve greater transparency and to comply
with internationally prevalent norms of Corporate Governance,
has voluntarily adopted Corporate Governance Standards
codified in Section 303A of New York Stock Exchange (NYSE)
Listed Company Manual. The details of the same and the
steps taken by the Company are explained in the Corporate
Governance Report.

Compliance of Secretarial Standards of ICSI

In terms of Section 118(10) of the Act, the Company is
complying with the applicable Secretarial Standards issued
by the Institute of Company Secretaries of India and approved
by Central Government.

Business Responsibility and Sustainability Report

In compliance with SEBI Listing Regulations, Business
Responsibility and Sustainability Report detailing the various
initiatives taken by the Company on environmental, social and
governance front is forming a part of this Annual Report. The
Board of Directors has adopted a Business Responsibility
Policy which is available on Company's website at
https://
www.baiaiconsumercare.com/policies.php.

Energy Conservation, Technology Absorption
and Foreign Exchange Earnings and Outgo

The disclosure of particulars with respect to Conservation
of Energy, Technology Absorption and Foreign Exchange

Earnings and Outgo as required under Section 134(3)(m) of the
read with Rule 8(3) of the Companies (Accounts) Rules, 2014
is annexed herewith as
Annexure-4 to this Directors' Report.

Annual Return

The Annual Return as provided under Section 92(3) of the
Act and as prescribed in Form No. MGT-7 of the Companies
(Management and Administration) Rules, 2014, is available
on the website of the Company at
https://bajajconsumercare.
com/qeneral-meetinqs-postalballots-aqm.php.

Disclosure under the Sexual Harassment of
Women at Workplace (Prevention, Prohibition
and Redressal) Act, 2013

The Company has in place a policy for prevention of sexual
harassment at the workplace in line with the requirements
of Sexual Harassment of Women at Workplace (Prevention,
Prohibition and Redressal) Act, 2013. An Internal complaints
committee has been set up to redress complaints, if any
received regarding sexual harassment at workplace.

The following is the summary of sexual harassment complaints
received and disposed off during the year under review.

1. Number of Complaints received: 1

2. Number of Complaints disposed off: 1.

Particulars of Employees

The disclosures pertaining to remuneration and other details
as required under Section 197(12) of the Act read with Rule
5(1) of the Companies (Appointment and Remuneration
of Managerial Personnel) Rules, 2014 are provided in
Annexure-5 forming part of this Directors' Report.

In accordance with the first proviso to Section 136(1) of the
Act, the Directors' Report is being circulated to the Members
excluding the statement containing particulars of employees
as required under Section 197(12) of the Act read with Rule
5 of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014. The said statement is
available for inspection by the Members at the Registered
Office of the Company during business hours on all working
days, except Saturdays, Sundays and National Holidays, up to
the date of the 20th Annual General Meeting (AGM).

Any Member interested in obtaining a copy of the said
statement or inspecting the same may write to the Company
Secretary in advance.

Further, it is hereby confirmed that the Managing Director of the
Company does not receive any remuneration or commission
from the Company's holding and/or subsidiary companies.

Listing Agreement

In compliance with SEBI Circular No. CIR/CFD/CMD/6/2015
dated October 13, 2015, the Company has executed a
Uniform Listing Agreement with BSE Limited and National
Stock Exchange of India Limited, where Equity Shares of the
Company are listed. Company has paid annual listing fees to
both the Stock Exchanges.

Prohibition of Insider Trading

In compliance with SEBI (Prohibition of Insider Trading)
Regulations, 2015, the Company has adopted a 'Code of
Conduct for Regulating, Monitoring and Reporting of Trading
by Insiders and 'Code of Fair Disclosure' of Unpublished
Price Sensitive Information to ensure prohibition of Insider
Trading in the Organisation. The said codes are available
on Company's website at
https://www.bajajconsumercare.
com/policies.php.

The 'Trading Window' is closed when the Compliance Officer
determines that a designated person or class of

designated persons can reasonably be expected to have
possession of Unpublished Price Sensitive Information. The
Company Secretary of the Company has been designated
as Compliance Officer to administer the Code of Conduct
and other requirements under SEBI (Prohibition of Insider
Trading) Regulations, 2015.

General Disclosure

During the year under review:

a) the Company has not issued Equity Shares with
differential rights as to dividend, voting or otherwise,
pursuant to the provisions of Section 43 of Act and Rules
made thereunder.

b) the Company has not made any provisions of money or
has not provided any loan to its employees for purchase
of shares of the Company or its holding Company,
pursuant to the provisions of Section 67 of Act and Rules
made thereunder.

c) the Company has not accepted any deposit from the
public, pursuant to the Chapter V of the Act and Rules

made thereunder

d) there are no significant material orders passed by
the Regulators/Courts which would impact the going
concern status of the Company and its future operations.

e) there was no occasion where the Board has not accepted
any recommendation of the Audit Committee.

f) no application was filed for corporate insolvency
resolution process, by a financial or operational creditor
or by the Company itself under the IBC before the NCLT.

Industrial Relations

Industrial relations have been cordial at all the manufacturing
units of the Company.

Cautionary Statement

Statements contained in the Directors' Report and the
Management Discussion and Analysis Report describing the
Company's objectives, expectations, estimates or predictions
may constitute "forward-looking statements" within the
meaning of applicable securities laws and regulations.

Actual results may differ materially from those expressed
or implied in such statements due to various risks and
uncertainties. Important factors that could influence the
Company's operations and performance include, but are not
limited to, global and domestic demand and supply conditions
affecting selling prices, capacity additions, availability and
cost of critical raw materials, changes in government policies
and tax laws, economic conditions and development within
the country, and other factors material to the Company's
business operations.

Acknowledgements

Your directors express their appreciation for the sincere
cooperation and assistance of Central and State Government
authorities, bankers, customers, suppliers and business
associates. Your directors also wish to place on record their
deep sense of appreciation for the committed services by
your Company's employees. Your directors acknowledge with
gratitude, the encouragement and support extended by our
valued shareholders.

For and on behalf of the Board of Directors

Kushagra Nayan Bajaj

Place: Mumbai Chairman

Date: April 17, 2026 (DIN:00017575)